CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,641
- in 2 filings
Net −$701,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise | +29,737 | $0.72 | $21K | 55,016 |
| 2026-08-17 | Aurora Daljit Singh See Remarks | Sale | −55,016 | $1.50 | $83K | 0 |
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −40,890 | 0 | ||
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −15,355 | 192,546 | ||
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −1,424 | 70,797 | ||
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −1 | 999,999 | ||
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −25,279 | 110,931 | ||
| 2026-08-17 | Aurora Daljit Singh See Remarks | Option exercise · Stock Option (Right to Buy) | −29,737 | 0 | ||
| 2026-05-27 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-05-27 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-05-27 | Piacquad David Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-05-27 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-05-27 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2026-02-17 | Aurora Daljit Singh See Remarks | Sale | −6,165 | $3.56 | $22K | 82,770 |
| 2026-02-17 | Pinto Joshua President | Sale | −5,967 | $3.54 | $21K | 57,783 |
| 2026-02-17 | BERNS PAUL L See Remarks | Sale | −9,819 | $3.51 | $34K | 7,395,185 |
| 2026-02-17 | Milligan Michael Lee See Remarks | Sale 10b5-1 | −1,436 | $3.57 | $5K | 21,034 |
| 2026-01-08 | Milligan Michael Lee See Remarks | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2026-01-08 | Aurora Daljit Singh See Remarks | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2026-01-08 | Duncan Jason See Remarks | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 |
Page 3 of 20 · 384 trades